Navigation Links
Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
Date:4/18/2011

HAYWARD, Calif., April 18, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that enrollment in the Phase 3 VISTA-16 study of varespladib in Acute Coronary Syndromes (ACS) will continue based on the positive outcome of an interim biomarker analysis and review of available patient safety data.

An independent statistician completed an analysis of various biomarkers of cardiovascular risk and determined that treatment with once-daily varespladib met the pre-specified criteria for the study to proceed.  The analysis required patients on varespladib to demonstrate pre-defined treatment effects versus placebo at relevant time points on a collection of biomarkers including:  secretory phospholipase A2 (sPLA2), low density lipoprotein cholesterol (LDL-C), C-reactive protein (CRP), interleukin-6 (IL-6), and a composite responder endpoint defined as patients achieving LDL-C less than 70 mg/dL and CRP below 1.0 mg/L.  

In parallel with the biomarker analysis, the VISTA-16 independent Data Safety and Monitoring Board (DSMB) completed a review of the available safety database including all reported adverse events and serious adverse events and recommended the continuation of the VISTA-16 clinical study without modification.  This represents the third meeting of DSMB since the start of the study.

"We continue to believe that positive changes in patient biomarkers similar to changes seen in the FRANCIS Phase 2 clinical study will correlate to a reduction in major adverse cardiovascular events in patients treated with varespladib for 16 weeks," said Paul F. Truex, President and Chief Executive Officer of Anthera Pharmaceuticals. "We are hopeful this approach will eventually prove that rapid and safe reduction of inflammation
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
2. Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
3. Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
4. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
5. Anthera Announces Update Call Regarding Vial Problems
6. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
7. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
8. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
9. Anthera Pharmaceuticals to Present at Deutsche Bank Securities 35th Annual Health Care Conference
10. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
11. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 Huntington Memorial Hospital is ... perform transcatheter aortic valve replacement (TAVR), a minimally invasive ... revolutionary new way to replace an aortic valve without ... lung machine. The procedure is performed by ... Azhil ( Alex) Durairaj , MD, interventional cardiologist and ...
(Date:3/26/2015)... March 26, 2015 According to ... Procedure Volume, Technology (RF, Microwave, Cryoablation, Others), Department (Interventional ... Cancer, Bone Metastasis) - Global Forecasts to 2019", published ... reach around $462.0 Million growing at a CAGR of ... tables and 57 figures spread through 195 pages and ...
(Date:3/26/2015)... 2015 A new survey of health ... research (CER) will yield improvements in health care ... impact of CER in the current environment. The ... stakeholders shows that they view CER as important, ... care and decision-making in the next three to ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4
... Oct. 30 Volunteers who guide low-income,and minority ... (LPN), help them to overcome major obstacles that ... outcomes, according to a,study presented October 28, 2007, ... 49th Annual Meeting in Los Angeles. Minority ...
... 30 Leading researchers,will present 68 data ... alfa-2b) and REBETOL(R),(ribavirin, USP) combination therapy, a ... chronic hepatitis C, at the 58th American ... Annual Meeting in Boston, Nov. 2-6. ...
Cached Medicine Technology:Patient Navigators Help Minority, Low-Income Cancer Patients Get Life-Saving Treatments 2Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting 7
(Date:3/26/2015)... San Frencisco, CA (PRWEB) March 26, 2015 ... Implant Center are proud to announce expanded offerings for ... The San Francisco Dental Implant Center has long been ... efforts have expanded its offerings to meet the strong ... pride in our reputation as a top-rated dental implant ...
(Date:3/26/2015)... 26, 2015 Innovative research and ... and preventing often fatal ruptures, says The Bee ... raising awareness of brain aneurysms and funding innovative ... captured national attention with the death of ... died last Friday after suffering a ruptured brain ...
(Date:3/26/2015)... Washington DC (PRWEB) March 26, 2015 ... Center for Assessment and Evaluation , has ... technologies that enable institutions, organizations, and corporations to ... to promote successful learning. , Utilizing Questionmark’s ... Testing Services will offer improved delivery of ...
(Date:3/26/2015)... New York, NY (PRWEB) March 26, 2015 ... year to raise awareness of Parkinson’s disease and funds ... (APDA) purpose to Ease the Burden – Find the ... for registration and will take place in more than ... Phoenix, Rhode Island, New Jersey, San Antonio, Minnesota, Seattle, ...
(Date:3/26/2015)... 26, 2015 Leading nutritional supplement ... company website: http://www.metabolicnutrition.com . The ultramodern, ... creates a user-friendly experience for consumers seeking information ... The new, enhanced Metabolic Nutrition website includes: , ... company’s diverse line of products, conveniently broken down ...
Breaking Medicine News(10 mins):Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 2Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 3Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:American Parkinson Disease Association 2015 Optimism Walk Season Launches Nationwide 2Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2
... HealthDay Reporter , TUESDAY, April 19 (HealthDay News) -- ... shorter recovery time in hospital than they did almost two ... hospitals have soared as a result, Iowa researchers report. ... done between 1991 and 2008, the researchers found that hospital ...
... the University of California, San Diego School of Medicine ... in people may be useful as a future biomarker ... and, in sufficient concentration, used as a treatment for ... by Richard Schwab, MD, assistant clinical professor of medicine, ...
... associated with a rare form of lymphoma, but there is not ... or to suggest an underlying mechanism for how the disease might ... The study, published online by the journal Plastic ... slow course and can be controlled by surgical removal of the ...
... are so involved with trying to eat virtuously that they are ... as healthy, according to a new study in the Journal ... can work to their disadvantage. "Keeping your weight-loss goal in ... are careful to avoid pasta selections and instead order from the ...
... surprising association of two intracellular proteins, University of Iowa ... new therapies to treat B cell lymphomas and autoimmune ... the viral protein Latent Membrane Protein 1 (LMP1), which ... of its role in the proliferation and survival of ...
... HealthDay Reporter , MONDAY, April 18 (HealthDay ... way, experts are cautioning that many parents don,t take ... commonplace sprains, bruises and pulled muscles "just part of ... 38 million American kids participating in sports each year ...
Cached Medicine News:Health News:Shorter Hospital Stays, More Readmissions After Hip Replacements 2Health News:Shorter Hospital Stays, More Readmissions After Hip Replacements 3Health News:A cancer marker and treatment in 1? 2Health News:A cancer marker and treatment in 1? 3Health News:Study confirms link between breast implants and rare form of cancer 2Health News:Study confirms link between breast implants and rare form of cancer 3Health News:When a salad is not a salad: Why are dieters easily misled by food names? 2Health News:Discovery of relationship between proteins may impact development of cancer therapies 2Health News:Too Many Parents Think Injuries Are 'Part of the Game' 2Health News:Too Many Parents Think Injuries Are 'Part of the Game' 3
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTN/1Q-CAB chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTN/1Q-CAB chairs are recommended for ... clean room, static control, health care ...
Medicine Products: